BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mercogliano MF, Bruni S, Mauro F, Elizalde PV, Schillaci R. Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy. Cancers (Basel) 2021;13:564. [PMID: 33540543 DOI: 10.3390/cancers13030564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nordin FJ, Pearanpan L, Chan KM, Kumolosasi E, Yong YK, Shaari K, Rajab NF. Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages. PLoS One 2021;16:e0256012. [PMID: 34379689 DOI: 10.1371/journal.pone.0256012] [Reference Citation Analysis]
2 Zarychta E, Ruszkowska-ciastek B. Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View. Biomedicines 2022;10:300. [DOI: 10.3390/biomedicines10020300] [Reference Citation Analysis]
3 Gubernatorova EO, Polinova AI, Petropavlovskiy MM, Namakanova OA, Medvedovskaya AD, Zvartsev RV, Telegin GB, Drutskaya MS, Nedospasov SA. Dual Role of TNF and LTα in Carcinogenesis as Implicated by Studies in Mice. Cancers (Basel) 2021;13:1775. [PMID: 33917839 DOI: 10.3390/cancers13081775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Benoot T, Piccioni E, De Ridder K, Goyvaerts C. TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer? Int J Mol Sci 2021;22:8691. [PMID: 34445397 DOI: 10.3390/ijms22168691] [Reference Citation Analysis]
5 Zhang Z, Wu P, Zhang C, Luo Y, Zhang G, Zeng Q, Wang L, Yang Z, Sun N, He J. Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer. Front Immunol 2021;12:745769. [PMID: 34867972 DOI: 10.3389/fimmu.2021.745769] [Reference Citation Analysis]
6 Fereydouni M, Motaghed M, Ahani E, Kafri T, Dellinger K, Metcalfe DD, Kepley CL. Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer. Front Oncol 2022;12:830199. [DOI: 10.3389/fonc.2022.830199] [Reference Citation Analysis]
7 Ergun Y, Esen SA, Bardakci M, Ucar G, Kalkan Z, Urakci Z, Seyran E, Dogan M, Eren T, Aslan V, Kahraman S, Genc EE, Acikgoz Y, Dirikoc M, Esen I, Uncu D. Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors. Cancer Biomark 2021. [PMID: 35001878 DOI: 10.3233/CBM-210455] [Reference Citation Analysis]
8 Dall'Olio FG, Marabelle A, Caramella C, Garcia C, Aldea M, Chaput N, Robert C, Besse B. Tumour burden and efficacy of immune-checkpoint inhibitors. Nat Rev Clin Oncol 2021. [PMID: 34642484 DOI: 10.1038/s41571-021-00564-3] [Reference Citation Analysis]